Allergy, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 72288-8...

FDA Recall #D-0900-2023 — Class II — February 9, 2023

Recall #D-0900-2023 Date: February 9, 2023 Classification: Class II Status: Terminated

Product Description

Allergy, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 72288-847-39), and b)150-count cartons (NDC 72288-847-47 and 72288-847-37), Distributed By: Amazon.com Services LLC., 410 Terry Avenue N., Seattle, WA 98109.

Reason for Recall

Failed Impurities/Degradation Specifications

Recalling Firm

L. Perrigo Company — Allegan, MI

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

11,904 cartons

Distribution

Nationwide within the USA

Code Information

Lot # a) 2GR0329, Exp. date 04/24 Lot # b) 2DR0472, Exp. date 02/23; 2MR0417, Exp. date 07/24

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated